Alan Majchrowicz Photography

  • Home
  • Blog
  • Archive
    • All Galleries
    • Search
    • Cart
    • Lightbox
    • Client Area
  • Facebook
  • Twitter
x

Search Results

Refine Search
Match all words
Match any word
Prints
Personal Use
Royalty-Free
Rights-Managed
(leave unchecked to
search all images)
Prev Next
212 images found
twitterlinkedinfacebook

Loading ()...

  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42344.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42343.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42342.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42341.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42338.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42336.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42331.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42328.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42326.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42325.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42324.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42321.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42320.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42319.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42318.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42317.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42315.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42311.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42310.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42305.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42304.jpg
  • The Three Judges, Goblin Valley State Park Utah
    am_091017_28573.jpg
  • The Three Judges, Goblin Valley State Park Utah
    am_091017_28570.jpg
  • The Three Gossips, Arches National Park Utah USA
    am_091013_27171.jpg
  • The Three Gossips, Arches National Park Utah USA
    am_091013_27166.jpg
  • The Three Gossips, Arches National Park Utah USA
    am_091013_27161.jpg
  • The Three Gossips, Arches National Park Utah USA
    am_091011_26379.jpg
  • The Three Gossips, Arches National Park Utah USA
    am_091011_26372.jpg
  • The Three Gossips, Arches National Park Utah USA
    am_091011_26360.jpg
  • The Three Gossips, Arches National Park Utah USA
    am_091011_26355.jpg
  • The Three Gossips, Arches National Park Utah USA
    am_091011_26238.jpg
  • The Three Gossips and Courthouse Buttes, Arches National Park Utah USA
    am_091011_26208.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24730.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24729.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24727.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24726.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24725.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24724.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24723.jpg
  • Close-up of Rebif syringe. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24720.jpg
  • Discarded syringes of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24719.jpg
  • Discarded syringes of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24717.jpg
  • Syringe dosage of Rebif against injection instructions. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24715.jpg
  • Syringe dosage of Rebif against injection instructions. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24711.jpg
  • Syringe dosage of Rebif against injection instructions. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24710.jpg
  • Broken Top Mountain from Green Lakes Basin, Three Sisters Wilderness Oregon
    am_020705_3936.jpg
  • Morning light on South Sister from Green Lakes, Three Sisters Wilderness Oregon USA
    am_020620_3930.jpg
  • Morning light on South Sister from Green Lakes, Three Sisters Wilderness Oregon USA
    am_020620_3929.jpg
  • Swift Creek Valley in winter, seen from Artist Point. White Horse and Three Fingers Mountains are in the distance. North Cascades Washington
    am_190205_64723.jpg
  • Swift Creek Valley in winter, seen from Artist Point. White Horse and Three Fingers Mountains are in the distance. North Cascades Washington
    am_190205_64726.jpg
  • Three people viewing Admiralty Inlet from Fort Casey State Park, Washington
    am_180421_62158.jpg
  • Ice encased trees or Krummholz on the summit of Three Brothers Mountain, Manning Provincial Park British Columbia Canada
    am_100121_33261.jpg
  • Ice encased trees or Krummholz on the summit of Three Brothers Mountain, Manning Provincial Park British Columbia Canada
    am_100121_33249.jpg
  • Ice encased trees or Krummholz on the summit of Three Brothers Mountain, Manning Provincial Park British Columbia Canada
    am_100121_33246.jpg
  • Ice encased trees or Krummholz on the summit of Three Brothers Mountain, Manning Provincial Park British Columbia Canada
    am_100121_33239.jpg
  • Ice encased trees or Krummholz on the summit of Three Brothers Mountain, Manning Provincial Park British Columbia Canada
    am_100121_33238.jpg
  • Ice encased trees or Krummholz on the summit of Three Brothers Mountain, Manning Provincial Park British Columbia Canada
    am_100121_33235.jpg
  • Ice encased trees or Krummholz on the summit of Three Brothers Mountain, Manning Provincial Park British Columbia Canada
    am_100121_33234.jpg
  • Ice encased trees or Krummholz on the summit of Three Brothers Mountain, Manning Provincial Park British Columbia Canada
    am_100121_33232.jpg
  • Ice encased trees or Krummholz on the summit of Three Brothers Mountain, Manning Provincial Park British Columbia Canada
    am_100121_33229.jpg
  • Ice encased trees or Krummholz on the summit of Three Brothers Mountain, Manning Provincial Park British Columbia Canada
    am_100121_33223.jpg
  • Sun bleached trees stand out among the black lava fields of McKenzie Pass Oregon. The Three Sisters volcanoes are in the distance.
    am_101017_42526.jpg
  • Sun bleached trees stand out among the black lava fields of McKenzie Pass Oregon. The Three Sisters volcanoes are in the distance.
    am_101017_42525.jpg
  • Sun bleached trees stand out among the black lava fields of McKenzie Pass Oregon. The Three Sisters volcanoes are in the distance.
    am_101017_42524.jpg
  • Sun bleached trees stand out among the black lava fields of McKenzie Pass Oregon. The Three Sisters volcanoes are in the distance.
    am_101017_42514.jpg
  • Sun bleached trees stand out among the black lava fields of McKenzie Pass Oregon. The Three Sisters volcanoes are in the distance.
    am_101017_42510.jpg
  • Sun bleached trees stand out among the black lava fields of McKenzie Pass Oregon. The Three Sisters volcanoes are in the distance.
    am_101017_42496.jpg
  • Sun bleached trees stand out among the black lava fields of McKenzie Pass Oregon. The Three Sisters volcanoes are in the distance.
    am_101017_42458.jpg
  • Sun bleached trees stand out among the black lava fields of McKenzie Pass Oregon. The Three Sisters volcanoes are in the distance.
    am_101017_42440.jpg
  • Sun bleached trees stand out among the black lava fields of McKenzie Pass Oregon. The Three Sisters volcanoes are in the distance.
    am_101017_42431.jpg
  • Sun bleached trees stand out among the black lava fields of McKenzie Pass Oregon. The Three Sisters volcanoes are in the distance.
    am_101017_42420.jpg
  • Sun bleached trees stand out among the black lava fields of McKenzie Pass Oregon. The Three Sisters volcanoes are in the distance.
    am_101017_42402.jpg
  • Sun bleached trees stand out among the black lava fields of McKenzie Pass Oregon. The Three Sisters volcanoes are in the distance.
    am_101017_42393.jpg
  • Sun bleached trees stand out among the black lava fields of McKenzie Pass Oregon. The Three Sisters volcanoes are in the distance.
    am_101017_42384.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42351.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42340.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42334.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42327.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42323.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42314.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42312.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42309.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42350.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42333.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42307.jpg
  • Proxy Falls near McKenzie Pass in the Three Sisters Wilderness, Oregon
    am_101016_42303.jpg
  • The Three Judges, Goblin Valley State Park Utah
    am_091017_28572.jpg
  • The Three Gossips, Arches National Park Utah USA
    am_091011_26218.jpg
  • The Three Gossips, Arches National Park Utah USA
    am_091011_26183.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24732.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24731.jpg
  • Nightstand displaying various MS medications along with cup of tea. The syringe is a dosage of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24728.jpg
  • Close-up of Rebif syringe. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24722.jpg
  • Close-up of Rebif syringe. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24721.jpg
  • Discarded syringes of Rebif. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24718.jpg
  • Syringe dosage of Rebif against injection instructions. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24716.jpg
  • Syringe dosage of Rebif against injection instructions. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24713.jpg
  • Syringe dosage of Rebif against injection instructions. A one month supply of Rebif can cost anywhere from $1,600 to more than $2,000 USD. Rebif is a disease-modifying drug (DMD) used to treat multiple sclerosis in cases of clinically isolated syndromes as well as relapsing forms of multiple sclerosis and is similar to the interferon beta protein produced by the human body. It is co-marketed by EMD Serono and Pfizer in the US under an exception to the Orphan Drug Act. It was approved in Europe in 1998 and in the US in 2002 and is registered in more than 80 countries worldwide. Rebif is administered via subcutaneous injection three times per week, and can be stored at room temperature for up to 30 days.
    am_090821_24712.jpg
  • Broken Top Mountain from Green Lakes Basin, Three Sisters Wilderness Oregon
    am_020705_3935.jpg
  • Detail of the face of Ross Dam, one of three dams on the Upper Skagit River Washington
    am_080518_16334.jpg
Prev Next